Literature DB >> 12714377

Induction of regulated upon activation, normal T cells expressed and secreted (RANTES) and transforming growth factor-beta 1 in airway epithelial cells by Mycoplasma pneumoniae.

Azzeddine Dakhama1, Monica Kraft, Richard J Martin, Erwin W Gelfand.   

Abstract

Mycoplasma pneumoniae infection exacerbates asthma in children and may play a role in the pathogenesis of chronic asthma. Because the airway epithelium is a preferential site for M. pneumoniae infection and a major source of the chemokine regulated on activation, normal T cells expressed and secreted (RANTES) and transforming growth factor (TGF)-beta1, we postulated that this microorganism may contribute to the disease by inducing these mediators through direct interaction with airway epithelial cells. We investigated the effects of M. pneumoniae on RANTES and TGF-beta1 production in primary cultures of normal human bronchial epithelial (NHBE) cells and small airway epithelial (SAEC) cells. Both cell types were permissive to M. pneumoniae infection in vitro, but their responses were different. TGF-beta1 was induced at higher levels in NHBE than in SAEC cultures, whereas RANTES was induced in SAEC cultures but not in NHBE cultures. These effects were attenuated by erythromycin and dexamethasone. In vitro adherence assays further indicated that the effects of erythromycin were mediated through its antimicrobial action, resulting in diminished adherence of the pathogen, whereas the effects of dexamethasone did not appear to be by inhibition of adherence. These results suggest that M. pneumoniae infection may contribute to the pathogenesis of chronic asthma at different levels of the airways, by inducing TGF-beta1 in large airways and the chemokine RANTES in small airways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12714377     DOI: 10.1165/rcmb.2002-0291OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  11 in total

Review 1.  Cells and Culture Systems Used to Model the Small Airway Epithelium.

Authors:  Rudra Bhowmick; Heather Gappa-Fahlenkamp
Journal:  Lung       Date:  2016-04-12       Impact factor: 2.584

2.  Resolvin D1 attenuates polyinosinic-polycytidylic acid-induced inflammatory signaling in human airway epithelial cells via TAK1.

Authors:  Hsi-Min Hsiao; Thomas H Thatcher; Elizabeth P Levy; Robert A Fulton; Kristina M Owens; Richard P Phipps; Patricia J Sime
Journal:  J Immunol       Date:  2014-10-15       Impact factor: 5.422

Review 3.  Mycoplasmas as Host Pantropic and Specific Pathogens: Clinical Implications, Gene Transfer, Virulence Factors, and Future Perspectives.

Authors:  Ali Dawood; Samah Attia Algharib; Gang Zhao; Tingting Zhu; Mingpu Qi; Kong Delai; Zhiyu Hao; Marawan A Marawan; Ihsanullah Shirani; Aizhen Guo
Journal:  Front Cell Infect Microbiol       Date:  2022-05-13       Impact factor: 6.073

4.  The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection.

Authors:  C Tagliabue; C M Salvatore; C Techasaensiri; A Mejias; J P Torres; K Katz; A M Gomez; S Esposito; N Principi; R D Hardy
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

5.  Inhibition of message for FcepsilonRI alpha chain blocks mast cell IL-4 production induced by co-culture with Mycoplasma pneumoniae.

Authors:  Danlin Luo; Yuling Dai; Lynn B Duffy; T Prescott Atkinson
Journal:  Microb Pathog       Date:  2007-10-24       Impact factor: 3.738

6.  Identification of a mechanism for lung inflammation caused by Mycoplasma pneumoniae using a novel mouse model.

Authors:  Takeshi Saraya; Koh Nakata; Kazuhide Nakagaki; Natsuki Motoi; Kuniko Iihara; Yasunori Fujioka; Teruaki Oka; Daisuke Kurai; Hiroo Wada; Haruyuki Ishii; Haruhiko Taguchi; Shigeru Kamiya; Hajime Goto
Journal:  Results Immunol       Date:  2011-11-11

Review 7.  Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications.

Authors:  Takeshi Saraya; Daisuke Kurai; Kazuhide Nakagaki; Yoshiko Sasaki; Shoichi Niwa; Hiroyuki Tsukagoshi; Hiroki Nunokawa; Kosuke Ohkuma; Naoki Tsujimoto; Susumu Hirao; Hiroo Wada; Haruyuki Ishii; Koh Nakata; Hirokazu Kimura; Kunihisa Kozawa; Hajime Takizawa; Hajime Goto
Journal:  Front Microbiol       Date:  2014-08-11       Impact factor: 5.640

8.  Decreased interleukin-18 response in asthmatic children with severe Mycoplasma pneumoniae pneumonia.

Authors:  Hai Lee Chung; Jin Young Shin; Mi Ju; Woo Taek Kim; Sang Gyung Kim
Journal:  Cytokine       Date:  2011-02-26       Impact factor: 3.861

Review 9.  Controversy surrounding the increased expression of TGF beta 1 in asthma.

Authors:  Ynuk Bossé; Marek Rola-Pleszczynski
Journal:  Respir Res       Date:  2007-09-24

10.  Low-dose, long-term macrolide therapy in asthma: An overview.

Authors:  Umur Hatipoglu; Israel Rubinstein
Journal:  Clin Mol Allergy       Date:  2004-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.